Menin associates with FANCD2, a protein involved in repair of DNA damage

Cancer Research

Volumn 63, Issue 14, 2003, Pages 4204-4210

  Jin, Shenghao ^a   Mao, Hua ^a   Schnepp, Robert W ^a   Sykes, Stephen M ^a   Silva, Albert C ^a   D'Andrea, Alan D ^b   Hua, Xianxin ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN; PROTEIN FANCD 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; FANCONI ANEMIA; GAMMA IRRADIATION; GENE MUTATION; HUMAN; HUMAN CELL; MULTIPLE ENDOCRINE NEOPLASIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; CHROMATIN; DNA; DNA DAMAGE; DNA REPAIR; FANCONI ANEMIA COMPLEMENTATION GROUP D2 PROTEIN; FEMALE; HELA CELLS; HUMANS; MALE; MICE; MOLECULAR SEQUENCE DATA; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; SUBCELLULAR FRACTIONS; TRANSFECTION;

EID: 0043175232     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Hoff, A. O., Cote, G. J., and Gagel, R. F. Multiple endocrine neoplasias. Annu. Rev. Physiol., 62: 377-411, 2000.
2. Marx, S. J. Multiple Endocrine Neoplasia Type I. In: B. Vogelstein and K. W. Kinzler (eds.), The Genetic Basis of Human Cancer, pp. 489-506. New York: McGraw-Hill, 1998.
3. Marx, S. J., Agarwal, S. K., Kester, M. B., Heppner, C., Kim, Y. S., Skarulis, M. C., James, L. A., Goldsmith, P. K., Saggar, S. K., Park, S. Y., Spiegel, A. M., Burns, A. L., Debelenko, L. V., Zhuang, Z., Lubensky, I. A., Liotta, L. A., Emmert-Buck, M. R., Guru, S. C., Manickam, P., Crabtree, J., Erdos, M. R., Collins, F. S., and Chandrasekharappa, S. C. Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias. Recent Prog. Horm. Res., 54: 397-438, 1999.
4. Pannett, A. A., and Thakker, R. V. Multiple endocrine neoplasia type 1. Endocr. Relat. Cancer, 6: 449-473, 1999.
5. Chandrasekharappa, S. C., Guru, S. C., Manickam, P., Olufemi, S. E., Collins, F. S., Emmert-Buck, M. R., Debelenko, L. V., Zhuang, Z., Lubensky, I. A., Liotta, L. A., Crabtree, J. S., Wang, Y., Roe, B. A., Weisemann, J., Boguski, M. S., Agarwal, S. K., Kester, M. B., Kim, Y. S., Heppner, C., Dong, Q., Spiegel, A. M., Burns, A. L., and Marx, S. J. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science (Wash. DC), 276: 404-407, 1997.
6. Crabtree, J. S., Scacheri, P. C., Ward, J. M., Garrett-Beal, L., Emmert-Buck, M. R., Edgemon, K. A., Lorang, D., Libutti, S. K., Chandrasekharappa, S. C., Marx, S. J., Spiegel, A. M., and Collins, F. S. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc. Natl. Acad. Sci. USA. 98: 1118-1123, 2001.
7. Kim, Y. S., Burns, A. L., Goldsmith, P. K., Heppner, C., Park, S. Y., Chandrasekharappa, S. C., Collins, F. S., Spiegel, A. M., and Marx, S. J. Stable overexpression of MEN1 suppresses tumorigenicity of RAS. Oncogene. 18: 5936-5942, 1999.
8. Guru, S. C., Goldsmith, P. K., Burns, A. L., Marx, S. J., Spiegel, A. M., Collins, F. S., and Chandrasekharappa, S. C. Menin, the product of the MEN1 gene, is a nuclear protein. Proc. Natl. Acad. Sci. USA, 95: 1630-1634, 1998.
9. Agarwal, S. K., Guru, S. C., Heppner, C., Erdos, M. R., Collins, R. M., Park, S. Y., Saggar, S., Chandrasekharappa, S. C., Collins, F. S., Spiegel, A. M., Marx, S. J., and Burns, A. L. Menin interacts with the API transcription factor JunD and represses JunD-activated transcription. Cell, 96: 143-152, 1999.
10. Heppner, C., Bilimoria, K. Y., Agarwal, S. K., Kester, M., Whitty, L. J., Guru, S. C., Chandrasekharappa, S. C., Collins, F. S., Spiegel, A. M., Marx, S. J., and Burns, A. L. The tumor suppressor protein menin interacts with NF-κB proteins and inhibits NF-κB-mediated transactivation. Oncogene, 20: 4917-4925, 2001.
11. Kaji, H., Canaff, L., Lebrun, J. J., Goltzman, D., and Hendy, G. N. Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type β signaling. Proc. Natl. Acad. Sci. USA, 98: 3837-3842, 2001.
12. Sukhodolets, K., Hickman, A., Agarwal, S. K., Sukhodolets, M., Obungu, V., Novotny, E., Crabtree, J., Chandrasekharappa, S. C., Collins, F. S., Spiegel, A. M., Burns, A. L., and Marx, S. J. The 32-kilodalton subunit of replication protein A interacts with menin, the product of the MEN1 tumor suppressor gene., Mol. Cell. Biol., 23: 493-509, 2003.
13. Gustavson, K. H., Jansson, R., and Oberg, K. Chromosomal breakage in multiple endocrine adenomatosis (types I and II). Clin Genet., 23: 143-149, 1983.
14. Scappaticci, S., Maraschio, P., del Ciotto, N., Fossati, G. S., Zonta, A., and Fraccaro, M. Chromosome abnormalities in lymphocytes and fibroblasts of subjects with multiple endocrine neoplasia type I. Cancer Genet Cytogenet., 52: 85-92, 1991.
15. Itakura, Y., Sakurai, A., Katai, M., Ikeo, Y., and Hashizume, K. Enhanced sensitivity to alkylating agent in lymphocytes from patients with multiple endocrine neoplasia type 1. Biomed Pharmacother., 54 (Suppl. 1): 187s-190s, 2000.
16. Tomassetti, P., Cometa, G., Del Vecchio, E., Baserga, M., Faccioli, P., Bosoni, D., Paolucci, G., and Barbara, L. Chromosomal instability in multiple endocrine neoplasia type 1. Cytogenetic evaluation with DEB test. Cancer Genet Cytogenet., 79: 123-126, 1995.
17. Hessman, O., Skogseid, B., Westin, G., and Akerstrom, G. Multiple allelic deletions and intratumoral genetic heterogeneity in men1 pancreatic tumors. J. Clin. Endocrinol. Metab., 86: 1355-1361, 2001.
18. Ikeo, Y., Sakurai, A., Suzuki, R., Zhang, M. X., Koizumi, S., Takeuchi, Y., Yumita, W., Nakayama, J., and Hashizume, K. Proliferation-associated expression of the MEN1 gene as revealed by in situ hybridization: possible role of the menin as a negative regulator of cell proliferation under DNA damage. Lab. Investig., 80: 797-804, 2000.
19. Garcia-Higuera, I., Taniguchi, T., Ganesan, S., Meyn, M. S., Timmers, C., Hejna, J., Grompe, M., and D'Andrea, A. D. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell., 7: 249-262, 2001.
20. Agarwal, S. K., Kester, M. B., Debelenko, L. V., Heppner, C., Emmert-Buck, M. R., Skarulis, M. C., Doppman, J. L., Kim, Y. S., Lubensky, I. A., Zhuang, Z., Green, J. S., Guru, S. C., Manickam, P., Olufemi, S. E., Liotta, L. A., Chandrasekharappa, S. C., Collins, F. S., Spiegel, A. M., Burns, A. L., and Marx, S. J. Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum. Mol. Genet., 6: 1169-1175, 1997.
21. Hua, X., Liu, X., Ansari, D. O., and Lodish, H. F. Synergistic cooperation of TFE3 and smad proteins in TGF-β-induced transcription of the plasminogen activator inhibitor-1 gene. Genes Dev., 12: 3084-3095, 1998.
22. La, P., Morgan, T., Sykes, S., Mao, H., Schnepp, R., Petersen, C., and Hua, X. Fusion proteins of retinoid receptors antagonize TGF-β-induced growth inhibition of lung epithelial cells. Oncogene, 22: 198-210, 2003.
23. Hua, X., Nohturfft, A., Goldstein, J. L., and Brown, M. S. Sterol resistance in CHO cells traced to point mutation in SREBP cleavage-activating protein. Cell, 87: 415-426, 1996.
24. Halbert, C. L., Demers, G. W., and Galloway, D. A. The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J. Virol., 65: 473-478, 1991.
25. Yang, Y., Kuang, Y., De Oca, R. M., Hays, T., Moreau, L., Lu, N., Seed, B., and D'Andrea, A. D. Targeted disruption of the murine Fanconi anemia gene, Fancg/Xrcc9. Blood, 98: 3435-3440, 2001.
26. Harlow, E., and Lane, D. Antibodies: A Laboratory Manual, Ed. 1. Cold Spring Harbor: Cold Spring Harbor Laboratory, 1988.
27. Qiao, F., Moss, A., and Kupfer, G. M. Fanconi anemia proteins localize to chromatin and the nuclear matrix in a DNA damage- and cell cycle-regulated manner. J. Biol. Chem., 276: 23391-23396, 2001.
28. Timmers, C., Taniguchi, T., Hejna, J., Reifsteck, C., Lucas, L., Bruun, D., Thayer, M., Cox, B., Olson, S., D'Andrea, A. D., Moses, R., and Grompe, M. Positional cloning of a novel Fanconi anemia gene. FANCD2. Mol. Cell., 7: 241-248, 2001.
29. Grompe, M., and D'Andrea, A. Fanconi anemia and DNA repair. Hum. Mol. Genet., 10: 2253-2259, 2001.
30. Zaidi, S. K., Javed, A., Choi, J. Y., van Wijnen, A. J., Stein, J. L., Lian, J. B., and Stein, G. S. A specific targeting signal directs Runx2/Cbfa1 to subnuclear domains and contributes to transactivation of the osteocalcin gene. J. Cell Sci., 114: 3093-102, 2001.
31. Dronkert, M. L., and Kanaar, R. Repair of DNA interstrand cross-links. Mutat. Res., 486: 217-247, 2001.
32. Joenje, H., and Patel, K. J. The emerging genetic and molecular basis of Fanconi anaemia. Nat. Rev. Genet., 2: 446-457, 2001.
33. Taniguchi, T., and Dandrea, A. D. Molecular pathogenesis of fanconi anemia. Int. J. Hematol., 75: 123-128, 2002.
34. Garcia-Higuera, I., Kuang, Y., Naf, D., Wasik, J., and D'Andrea, A. D. Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex. Mol. Cell. Biol., 19: 4866-4873, 1999.
35. Garcia-Higuera, I., Kuang, Y., Denham, J., and D'Andrea, A. D. The fanconi anemia proteins FANCA and FANCG stabilize each other and promote the nuclear accumulation of the Fanconi anemia complex. Blood, 96: 3224-3230, 2000.
36. Akkari, Y. M., Bateman, R. L., Reifsteck, C. A., D'Andrea, A. D., Olson, S. B., and Grompe, M. The 4N cell cycle delay in Fanconi anemia reflects growth arrest in late S phase. Mol. Genet. Metab., 74: 403-412, 2001.
37. Centurion, S. A., Kuo, H. R., and Lambert, W. C. Damage-resistant DNA synthesis in Fanconi anemia cells treated with a DNA cross-linking agent. Exp. Cell Res., 260: 216-221, 2000,
38. Sala-Trepat, M., Rouillard, D., Escarceller, M., Laquerbe, A., Moustacchi, E., and Papadopoulo, D. Arrest of S-phase progression is impaired in Fanconi anemia cells. Exp. Cell Res., 260: 208-215, 2000.
39. Taniguchi, T., Garcia-Higuera, I., Xu, B., Andreassen, P. R., Gregory, R. C., Kim, S. T., Lane, W. S., Kastan, M. B., and D'Andrea, A. D. Convergence of the Fanconi Anemia and Ataxia Telangiectasia signaling pathways. Cell, 109: 459-472, 2002.
40. Howlett, N. G., Taniguchi, T., Olson, S., Cox, B., Waisfisz, Q., De Die-Smulders, C., Persky, N., Grompe, M., Joenje, H., Pals, G., Ikeda, H., Fox, E. A., and D'Andrea, A. D. Biallelic inactivation of BRCA2 in Fanconi anemia. Science (Wash. Dc), 297: 606-609, 2002.
41. Ishov, A. M., Sotnikov, A. G., Negorev, D., Vladimirova, O. V., Neff, N., Kamitani, T., Yeh, E. T., Strauss, J. F., III, and Maul, G. G. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-I. J. Cell Biol., 147: 221-234, 1999.
42. Jiang, M., Axe, T., Holgate, R., Rubbi, C. P., Okorokov, A. L., Mee, T., and Milner, J. p53 binds the nuclear matrix in normal cells: binding involves the proline-rich domain of p53 and increases following genotoxic stress. Oncogene. 20: 5449-5458, 2001.
43. Konety, B. R., and Getzenberg, R. H. Nuclear structural proteins as biomarkers of cancer. J. Cell Biochem., (Suppl 32): 183-191, 1999.
44. Maul, G. G., Negorev, D., Bell, P., and Ishov, A. M. Review: properties and assembly mechanisms of ND10, PML bodies, or PODs. J. Struct. Biol., 129: 278-287, 2000.
45. Stein, G. S., van Wijnen, A. J., Stein, J. L., Lian, J. B., Montecino, M., Zaidi, K., and Javed, A. Subnuclear organization and trafficking of regulatory proteins: implications for biological control and cancer. J. Cell Biochem., (Suppl. 35): 84-92, 2000.
46. Bode, J., Benham, C., Ernst, E., Knopp, A., Marschalek, R., Strick, R., and Strissel, P. Fatal connections: when DNA ends meet on the nuclear matrix. J. Cell Biochem., (Suppl. 35): 3-22, 2000.
47. Bosman, F. T. The nuclear matrix in pathology. Virchows Arch., 435: 391-399, 1999.
48. Pederson, T. Thinking about a nuclear matrix. J. Mol. Biol., 277: 147-159, 1998.
49. Pederson, T. Half a century of "the nuclear matrix". Mol. Biol Cell., 11: 799-805, 2000.
50. Kamiuchi, S., Saijo, M., Citterio, E., de Jager, M., Hoeijmakers, J. H., and Tanaka, K. Translocation of Cockayne syndrome group A protein to the nuclear matrix: possible relevance to transcription-coupled DNA repair. Proc. Natl. Acad. Sci. USA, 99: 201-206, 2002.
51. Felsenfeld, G., Boyes, J., Chung, J., Clark, D., and Studitsky, V. Chromatin structure and gene expression. Proc. Natl. Acad. Sci. USA, 93: 9384-9388, 1996.
52. Felsenfeld, G., Clark, D., and Studitsky, V. Transcription through nucleosomes. Biophys. Chem., 86: 231-237, 2000.
53. Widom, J. Structure, dynamics, and function of chromatin in vitro. Annu. Rev. Biophys. Biomol. Struct., 27: 285-327, 1998.
54. Salomoni, P., and Pandolfi, P. P. The role of PML in tumor suppression. Cell, 108: 165-170, 2002.